NCT06305312 Community Services Navigation to Advance Health Equity in Breast Cancer Screening
| NCT ID | NCT06305312 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,450 participants |
| Start Date | 2024-04-30 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,450 participants in total. It began in 2024-04-30 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate if adding community services navigation to the standard referral process for social needs is an effective and scalable strategy for addressing disparities in follow-up to abnormal breast cancer screening results. The investigators will determine the effectiveness of social needs referrals combined with a community services navigation intervention in the screening mammography setting to improving breast screening outcomes in underserved women.
Eligibility Criteria
Inclusion Criteria: * English and Spanish speakers * Received an abnormal result of a screening mammogram * Self-reports at least one social need on the B-SINCERE Screener Exclusion Criteria: * Patients who are currently in treatment for breast cancer * Patients with a normal screening result. * Patients who do not exhibit at least 1 social need according to their SINCERE screening result. * Patients who don't speak English or Spanish * Cognitive limitations that impede informed consent * Patients living outside of Utah
Contact & Investigator
Elissa Ozanne, PhD
PRINCIPAL INVESTIGATOR
Huntsman Cancer Institute
Frequently Asked Questions
Who can join the NCT06305312 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06305312 currently recruiting?
Yes, NCT06305312 is actively recruiting participants. Contact the research team at Elissa.Ozanne@hsc.utah.edu for enrollment information.
Where is the NCT06305312 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT06305312 clinical trial?
NCT06305312 is sponsored by University of Utah. The principal investigator is Elissa Ozanne, PhD at Huntsman Cancer Institute. The trial plans to enroll 1,450 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.